Borch, T. H., Harbst, K., Rana, A. H., Andersen, R., Martinenaite, E., Kongsted, P., . . . Marie Svane, I. (2021). Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma. J Immunother Cancer.
シカゴスタイル引用形Borch, Troels Holz, et al. "Clinical Efficacy of T-cell Therapy After Short-term BRAF-inhibitor Priming in Patients With Checkpoint Inhibitor-resistant Metastatic Melanoma." J Immunother Cancer 2021.
MLA引用形式Borch, Troels Holz, et al. "Clinical Efficacy of T-cell Therapy After Short-term BRAF-inhibitor Priming in Patients With Checkpoint Inhibitor-resistant Metastatic Melanoma." J Immunother Cancer 2021.
警告: この引用は必ずしも正確ではありません.